Objective The widespread sale of complementary medicines in community pharmacy raises important questions regarding the responsibilities of pharmacists when selling complementary medicines. This study reviews the academic literature that explores a pharmacist's responsibilities when selling complementary medicines. Methods International Pharmaceutical Abstracts, Embase, PubMed, Cinahl, PsycINFO and Philosopher's index databases were searched for articles written in English and published between 1995 and 2017. Empirical studies discussing pharmacists' practices or perceptions, consumers' expectations and normative studies discussing ethical perspectives or proposing ethical frameworks related to pharmacists' responsibilities in selling complementary medicines were included in the review.
Introduction
Complementary medicines are widely used in many countries. [1] Products containing ingredients such as herbs, vitamins, minerals, nutritional supplements, homeopathic and certain aromatherapy preparations may be referred to as complementary medicines. [2] The use of complementary medicines is prevalent in many countries. In 2006, a national consumer survey reported that 67% of Australians had used a complementary medicine in the previous 12 months. [3] In the United States, a National Health Interview Survey (NHIS) found that approximately 38% of adults (about 4 in 10) used complementary medicine products in 2007. [4] Additionally, in 2010, a Natural Health Product Tracking Survey in Canada revealed that nearly 73% of the respondents have used a natural health product previously. [5] Moreover, in 2009, 12 million consumers in the UK reported using some form of complementary medicine in the last 12 months. [6] Consumers purchase complementary medicine products to improve general health, enhance the performance of everyday tasks or to manage specific health conditions. [3, 7] Complementary medicines are available from supermarkets, health food shops and pharmacies. Many consumers choose to purchase complementary medicines from a pharmacy. [8] Consumers often perceive that complementary medicines are natural and therefore safe. [8, 9] Some consumers perceive complementary medicines sold in pharmacies to be more effective and safer than the complementary medicines available in supermarkets. [10] Despite the widely held perception of safety, adverse effects of complementary medicines and interactions between complementary medicines and other medicines are well documented. [11] [12] [13] [14] While some complementary medicines have good evidence for effectiveness in certain health conditions, many complementary medicines lack this evidence. To have good evidence of effectiveness, a complementary medicine would need to demonstrate efficacy in a randomized trial in a sample of participants who sufficiently resemble the people who use the complementary medicine and circumstances of their use. [15] The lack of evidence for the effectiveness of a complementary medicine may be because the complementary medicine is ineffective, or because highquality efficacy studies are yet to be conducted. The lack of rigorous scientific evidence for many complementary medicines combined with their widespread sale in pharmacy raise important questions regarding the responsibilities of pharmacists when selling complementary medicines.
Pharmacy practice is guided by codes of ethics and professional conduct. The International Pharmaceutical Federation (FIP) provides a code of ethics relevant to all pharmacists, [16] while national professional bodies also provide codes of ethics and/or professional codes of conduct in most jurisdictions. FIP recommends the inclusion of obligations consistent with the well-known bioethical principles of autonomy, beneficence, non-maleficence and justice. The Pharmaceutical Society of Australia's (PSA) Code of Ethics for Pharmacists identifies the responsibilities for pharmacists in fairly general terms in line with the bioethical principles stated above. [17] For example, the PSA Code of Ethics suggests that a pharmacist should respect a consumer's right to autonomy and prevent the consumer from harm. The most recent version of the PSA Code of Ethics states that: 'A pharmacist will only purchase, supply or promote any medicine, complementary medicine, herbal remedy or other healthcare product where there is credible evidence of efficacy and the benefit of use outweighs the risk'. [18] This statement directs that pharmacists should only stock and sell complementary medicines that have credible evidence for effectiveness, but there is a lack of supporting discussion regarding the justification for this stance or whether or how it should be implemented. [18] The professional literature describing the ethical responsibilities of pharmacists in relation to the sale of complementary medicines tends to provide general advice, focusing on the identification of the conflicting principles at stake. The conflict between a pharmacist's retail and health professional role is frequently identified when discussing the responsibilities of pharmacists when selling complementary medicines. [10, 19] A recently published systematic review by Ung et al. [20] identified the responsibilities of pharmacists most commonly reported in the literature with regard to complementary medicine products. This study did not seek to explore the ethical perspectives of selling complementary medicines in pharmacy. No systematic review to date has sought to identify ethical frameworks or models utilized in the studies exploring the responsibilities of pharmacists when selling complementary medicines.
This study reviews the academic literature that explores the responsibilities of pharmacists when selling complementary medicines. The review seeks to address the fol- 
Methods

Search strategy
A literature search was conducted using International Pharmaceutical Abstracts (IPA), Embase, PubMed, Cinahl, PsycINFO and Philosopher's Index database. The International Pharmaceutical Abstracts database, Embase and PubMed databases were searched to identify biomedical and pharmacological literature; Cinahl database focuses on the nursing and allied health literature; PsycINFO covers behavioural and social science literature; and the Philosopher's Index database was used to identify literature in philosophy.
The following search terms were used in all databases to identify the studies published from 1995 to August 2017: (pharmacist* OR pharmacy OR pharmacies OR 'pharmacy practice') AND ('complementary medicine*' OR 'alternative medicine*' OR 'complementary therap*' OR 'alternative therap*' OR 'alternative medication' OR CAM OR herb* OR 'natural product' OR 'natural health product' OR 'dietary supplement*' OR homeopathic OR 'complementary and alternative medicine' OR 'traditional medicine'). The search strategy was adapted to meet the requirements of each database. The specific search strategy used to search the Embase database is presented in Table 1 . The final search was conducted on 4th September 2017. The reference lists of all included studies were searched for any additional studies.
Eligibility criteria
Full-text peer-reviewed empirical and normative research articles published in English were included if they met any of the following criteria: (1) explicitly addressed pharmacist responsibilities in selling complementary medicines, (2) identified perceptions or practices related to recommending or selling complementary medicines in pharmacy, (3) discussed ethics and/or professional practice of selling complementary medicines in pharmacy or (4) proposed an ethical or practical framework for pharmacist responsibilities when selling complementary medicines.
Any of the following types of publication were excluded: (1) editorials, (2) letters to the editor, (3) commentaries, (4) conference presentations or (5) studies assessing the efficacy of specific complementary medicine.
Data extraction and reporting
A data extraction sheet was developed to record the following: author(s), year, country/region of study, aim, type of study, method, study participants and key findings. Both authors (ASP and AL) were involved in developing and piloting the data extraction tool on a sample of included studies (10%). Disagreements were resolved through discussion. The primary author (ASP) then extracted data for the remaining studies. The reporting of this systematic review is consistent with the PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) statement.
The studies using interviews, focus group discussions or observations to collect data were categorized as qualitative studies. The studies that used quantitative data collection methods or analyses from survey instruments were categorized as quantitative studies. Studies examining the ethical and philosophical perspectives of selling complementary medicine in pharmacy were categorized as normative research.
Data analysis
Counts and frequencies were used to report the country of study, type and data collection method of the studies. The results of the included studies were analysed to identify the major themes identified in the empirical and normative studies.
Quality assessment
The quality assessment of the qualitative, quantitative, mixed method and systematic review studies was carried out using the 16-item quality assessment tool (QATSDD). [21] This tool was selected because it has demonstrated good reliability and validity when applied to a methodologically diverse set of research articles. [21] The QATSDD tool consists of 16 evaluative criteria, with two criteria solely for qualitative studies and two criteria solely for quantitative studies. All 16 items are applicable for the studies using mixed methods. A score is awarded for each criterion on a scale from 0 to 3 based on the guidance notes provided by Sirriyeh et al. [21] A maximum score of 42 can be achieved for qualitative and quantitative studies, and 48 for mixedmethods studies, with a higher score indicating higher quality.
Results
Study selection
A total of 4821 records were retrieved using IPA, Embase, PubMed, Cinahl, PsycINFO and Philosopher's Index databases. After adjusting for duplicates, 4346 remained. Of these, 4246 were excluded based on their title and abstract. The full text of the remaining 100 studies was assessed for eligibility, of which 58 studies met the inclusion criteria. Appendix lists the fifty-eight studies included in this review. The study selection process is illustrated in Figure 1 . 
Description of included studies
The majority of the studies included in this review were conducted in developed countries including Australia (17), Canada (4), UK (5), USA (6) and Ireland (2) . The remaining studies were conducted in countries including: Kuwait (3), Malaysia (3), Saudi Arabia (3), Singapore (1), South Africa (1), Japan (1), China (2), Iran (1), Palestine (1), Pakistan (1), Qatar (1) and Nigeria (1) . Almost all of the studies had an empirical focus, these studies include 34 quantitative studies, 15 qualitative studies, four mixedmethods studies and four systematic reviews. Only one normative study was identified that examined the ethical and philosophical perspectives of pharmacists selling complementary medicines. The empirical studies were given an overall quality assessment score based on the study design. The overall score is expressed as a percentage of the maximum possible score. The quality assessment scores are presented in Appendix. The normative study, Mendel, [22] was not evaluated by the QATSDD tool.
The quality assessment scores for the included studies ranged between 31% and 83%. The scores were found to be consistent across different study methods. The studies having low-quality assessment score were less likely to: provide an explicit statement of the theoretical framework or constructs applied to the research; explain the choice of sample size; explain the choice of data collection tool; or provide a thorough statistical assessment of reliability and validity of measurement tool.
Aims of the studies
The aims of the empirical studies were focused on assessing pharmacist, consumer and pharmacy student perceptions regarding a pharmacist's responsibilities when selling complementary medicines. The studies explored consumers' and pharmacy students' perceptions regarding the responsibilities of pharmacists when selling complementary medicines and pharmacists' attitudes, [10, [23] [24] [25] [26] knowledge, [24, 27, 28] practices [29] [30] [31] [32] regarding their responsibility when selling complementary medicines, and any perceived barriers to providing information [33] regarding complementary medicines in pharmacy.
The normative study aimed to explore ethical perspectives of selling complementary medicine in pharmacy. [22] Methods employed by the studies A majority of the included studies were quantitative studies that reported survey responses. Survey questionnaires were distributed by hand, by telephone, Internet or mail. Only half of the studies using the questionnaire discussed or assessed the reliability or validity of the tool. Most of these studies provided some basic explanation for the choice of data collection tool; typically, that the tool was used in a previous study. The qualitative studies conducted direct observation of consumer-pharmacist interaction, focus group discussions, face-to-face or telephone interviews.
Key findings of the included studies
Pharmacist perceptions of their responsibilities towards complementary medicines
Pharmacists consistently identified ensuring safe use and providing advice to consumers as their primary responsibilities when selling complementary medicines. For example, in a Canadian study that conducted semi-structured interviews, pharmacy and stakeholder leaders expressed that pharmacists have a responsibility to ensure consumer safety by preventing them from adverse effects and drugherb interactions that may result by the use of complementary medicines. [19] Similarly, an Australian study employing structural equation modelling found that majority of the pharmacists included in the study agreed that counselling about complementary medicines is a responsibility of pharmacist. [31] Studies that conducted survey and focus group discussions suggested that pharmacists should instigate conversation with consumers about their use of complementary medicines, [24, 34] and most pharmacists agreed that they should ask consumers about their use of complementary medicines. [24] Despite this, studies that surveyed pharmacists about what they actually do found that pharmacists rarely initiate communication with consumers about complementary medicines. [23, 28, 35] A number of studies sought to identify the barriers that pharmacists believe impede their ability to fulfil their responsibilities in relation to complementary medicines. [19, [36] [37] [38] [39] Pharmacists consistently described a lack of confidence in their knowledge and skills in relation to complementary medicines and a lack of comfort in answering specific questions about complementary medicines from consumers. Several studies have reported pharmacists' concerns regarding the lack of scientific evidence for effectiveness of many complementary medicines. [25, 30, 33, [37] [38] [39] [40] Consumer expectations from pharmacists selling complementary medicines Seven studies identified consumer expectations of the role of pharmacists in relation to complementary medicines. [9, 10, 19, 34, [41] [42] [43] These studies found that consumers would like pharmacists to answer their specific questions regarding complementary medicines and to provide counselling that met their individual needs.
Studies that sought consumer opinion on who should lead the interaction, tended to find that the consumer wanted to be in control of the interaction. [10, 34] Consumers expressed the view that they are active decisionmakers in relation to their own health. A Canadian study found that the consumers would like pharmacists to adopt a consultative role to help them identify and assess a range of information available about complementary medicines, but not necessarily make a final decision for them regarding the use of these medicines. [34] 
Ethical dilemmas
Six empirical studies and one systematic analysis provided modest discussion regarding the ethical perspectives of selling complementary medicines. Four of the six empirical studies were conducted in Australia and the other two studies in Qatar and Northern Ireland. The systematic analysis was mostly relevant to North American context. Each of these studies focused their ethical discussion on the conflict arising between pharmacists' business role and their role as a health professional in relation to the sale of complementary medicines. [10, 19, 40, [44] [45] [46] [47] The single normative study [22] in this review discussed the lack of scientific evidence for many complementary medicines. The author argued that different professionals including complementary medicine, pharmacy and medical professionals adopt different approaches when selling complementary medicines in pharmacy. Further, the author described that pharmacists may find it difficult to sell complementary medicines based on scientific evidence because many complementary medicines lack rigorous evidence for effectiveness. The author took the perspective that complementary medicine professionals such as naturopaths and homeopaths may not face this difficulty because their approach towards selling complementary medicine is not based on scientific evidence. The study does not provide detailed advice regarding selling complementary medicines that lack evidence for effectiveness.
The ethical framework employed to identify the responsibilities of pharmacists selling complementary medicines
Explicit ethical frameworks or approaches were not identified or employed in the studies included in the review. Most authors tended to discuss professional ethics in a way that is consistent with the bioethical principles of autonomy, beneficence, non-maleficence and justice. This is consistent with the codes of ethics within the pharmacy profession. While professional codes of ethics where referred to in some discussion related to the ethics of selling complementary medicines, none of the studies discussed explicit links between codes of ethics and pharmacists selling complementary medicines.
Discussion
The academic literature examining the responsibilities of pharmacists selling complementary medicine consists almost entirely of empirical studies. These studies identify the responsibilities of a pharmacist as perceived by pharmacists and consumers. The key findings of this review suggest that pharmacists and consumers commonly restate general responsibilities of pharmacists when asked regarding their views on the responsibilities of pharmacists selling complementary medicine. For instance, pharmacists perceive they are responsible for providing information and counselling to the consumers about complementary medicines. Pharmacists also view their responsibility in ensuring the safe use of complementary medicines. There are important questions about how pharmacists should apply these general principles in specific contexts. But these questions are not addressed in the existing literature.
This systematic review summarizes the academic research literature focused on the ethical responsibilities of pharmacists selling complementary medicines. A key strength of this systematic review is the inclusion of both the empirical pharmacy practice literature and the philosophical ethics literature. Limitations that need to be kept in mind include that the review was restricted to the studies published in the English language, and deliberately focuses on peer-reviewed empirical and normative research articles. It needs to be recognized that the ethical responsibilities of pharmacists are also discussed outside of this literature. An informal review of editorials, commentaries, letters to the editors and other professional literature was conducted, and this literature did not add to the findings of this review. It is possible that a more systematic attempt to collect letters, editorial and grey literature would provide a more comprehensive analysis. A recent systematic review by Ung et al. [20] identifies seven responsibilities of pharmacists that have been discussed in the literature. The three key responsibilities they identify are consistent with our findings. The seven responsibilities they identified in the literature are as follows: (1) to acknowledge the use; (2) to be knowledgeable about the complementary medicine products; (3) to ensure safe use of complementary medicine products; (4) to document the use of complementary medicine products; (5) to report ADRs related to complementary medicine products; (6) to educate about complementary medicine products; and (7) to collaborate with other healthcare professionals. Like this systematic review, Ung et al. acknowledges the need for additional explicit guidance regarding the responsibilities of pharmacists specific to the sale of complementary medicines.
There is a disconnect between what pharmacists perceive their responsibilities are and their practice in relation to complementary medicines. For example, pharmacists' perceive they are responsible for the provision of information, [10, 34, [48] [49] [50] but they do not routinely initiate conversation with consumers about complementary medicines. [23, 28, 35] Although pharmacists identify a concern regarding the lack of scientific evidence for complementary medicines, this does not appear to affect them selling these products. A secret-shopper investigation by a consumer advocacy group found that nearly one-third of Australian pharmacies recommended a complementary medicine for stress, most of which lacked scientific evidence for effectiveness. [51, 52] Pharmacists and pharmacy support staff often provided misleading or false information regarding the effectiveness of the product. The studies included in this review suggest that, when asked, pharmacists tend to justify the sale of complementary medicines in terms of consumer demand [53, 54] or their own or a family member's personal experiences regarding complementary medicines. [40] Despite identifying the responsibility in general terms, pharmacists appear to fulfil these responsibilities only in situations in which the consumer explicitly seeks advice from the pharmacist. If the consumer seeks information, it is the responsibility of the pharmacist to provide it. If the consumer seeks assurance that the complementary medicine is safe to use with their other medicines, then it is the pharmacist's responsibility to ensure the safety. The responsibilities of the pharmacist when the consumer does not explicitly seek information are not articulated in the literature. In this sense, pharmacists adopt a reactive rather than proactive role in regard to the sale of complementary medicines. Perhaps this could be seen as a sign that pharmacists' respect the autonomy of the consumer in relation to complementary medicines. If this is the case, it is not something that has been explicitly discussed or defended in the literature. What, for instance, are the limits on consumers' autonomy? Does the pharmacist have a responsibility to prevent harms in relation to complementary medicines in circumstances in which the consumer does not explicitly seek the advice of the pharmacist?
The sale of complementary medicines without rigorous scientific evidence for effectiveness raises important ethical concerns regarding the responsibilities of pharmacists. Is it ethical for pharmacists to sell complementary medicines that may not work? What information should pharmacists provide regarding these products? Several studies identified the responsibilities of pharmacists selling complementary medicines in terms of conflict arising between their business and health professional roles. This conflict is most easily seen in relation to the sale of complementary medicines that lack scientific evidence for effectiveness. However, the studies identifying the conflict make no attempt to provide guidance on appropriate ways to resolve the conflict.
Part of the problem is the methods employed to elicit perceptions regarding the responsibilities of pharmacists when selling complementary medicines. The studies included in the review generally asked questions such as: 'Do you think pharmacists should recommend complementary medicines?' [10] 'What should all pharmacists know and be able to do with respect to complementary medicine products?' [19] In other studies, pharmacists were asked to agree or disagree with the statement that 'pharmacists should regularly ask consumers if they are using complementary medicines'. [24] Questions such as these are general in tone and open to an obvious socially acceptable answer. Few studies employed methods or asked further interrogative questions to better understand how pharmacists respond to conflicts arising related to the sale of complementary medicines. Questions that go un-asked include: Should a pharmacist sell a complementary medicine that lacks evidence for effectiveness? If a pharmacist does sell a complementary medicine in such a situation, what information should they provide? What are the responsibilities of a pharmacist for harms that arise due to a complementary medicine sold in their pharmacy? Do these responsibilities differ depending on whether or not the pharmacist was involved in the sale? Another aspect that is not explicitly addressed in this literature is the relationship between how complementary medicines are regulated in different parts of the world and the responsibilities of pharmacists selling complementary medicines. It might be suggested that the responsibilities of pharmacists differ in jurisdictions in which there are stronger regulations regarding the manufacture and sale of complementary medicines. There is, however, evidence that contamination can be a problem even in countries with the moderate level of regulation of complementary medicines. [55] The current literature is characterized by the lack of adoption or discussion of any formal ethical framework. To the degree any ethical framework is employed, it is arguably principlism. Principlism is extensively used by healthcare professionals as it is easy to comprehend and provides a practical tool to assess the ethical features of a given situation. [56] This framework seeks to address ethical questions by applying the four bioethical principles of autonomy, beneficence, non-maleficence and justice. [57] Principlism is a helpful framework that identifies ethical concerns arising in a given situation; in the way that it is typically employed it does not provide detailed guidance regarding what should be done once a conflict is identified. [58] Richardson and Degrazia suggest that specifying the bioethical principles in the context of specific cases can be useful for resolving ethical conflicts in bioethics. [59, 60] Specified principlism is a method for justifying ethical decisions concerning specific cases (such as the sale of complementary medicines by pharmacists). [61] This approach is yet to be employed in the literature.
While principlism is a well-known and commonly used framework, virtue ethics may also contribute to a comprehensive ethical discussion regarding pharmacist responsibilities. The two approaches are not mutually exclusive. [62] Key virtues that may apply in this matter are truth telling, courage, honesty and humility. Applying the virtues that are relevant in the context of the sale of complementary medicines in pharmacy and using these in conjunction with principlism may contribute to further aid an informed discussion regarding determining the responsibilities of pharmacists in the context of particular cases.
This review identifies the need for a practical ethical advice regarding the responsibilities of pharmacists selling complementary medicines. Specified principlism, in conjunction with virtue ethics, provides the theoretical resources to develop an ethical framework for determining the specific responsibilities of pharmacists selling complementary medicines.
Conclusion
The existing pharmacy literature mainly consists of empirical studies describing the general role of pharmacists' selling complementary medicines. The studies discussing the ethical perspective of selling complementary medicine identify ethical conflicts that arise related to the sale of complementary medicines in pharmacy. There is a lack of further normative guidance for pharmacists regarding what should be done once the ethical conflict is identified. No explicit ethical framework is currently adopted to identify the responsibilities of pharmacists' selling complementary medicines. Progress can be made by providing practical ethical guidance for pharmacists regarding their specific responsibilities towards complementary medicines.
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